End Stage Renal Disease on HemodialysisNCT02860312
Long Term Physical Activity for Hemodialysis Patients
A study testing Intradialytic exercise on stationary bicycles and Non-exercising group in people with End Stage Renal Disease on Hemodialysis, run by AURA Sante.
Trial summary
Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. Read more about this study
- Who is it for?
- Ages 20 to 90 years
- Conditions the study is for
- End Stage Renal Disease on Hemodialysis
- What is being tested?
- Intradialytic exercise on stationary bicycles and Non-exercising group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- Sep 2016to May 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o.
Who cannot join
- Unstable angina,
- severe left ventricular dysfunction,
- Ejection fraction < 30%,
- severe peripheral arterial disease,
- lower extremity amputation,
- impossibility of physical effort: pain, uncontrolled bone/muscular disease,
- participation on another study.
About this study
Official title: Effects of One Year Perdialytic Physical Activity on Aerobic Capacities and Quality of Life in Hemodialysis Patients
Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. There are several studies- usually short term, single center uncontrolled and underpowered- that have shown a significant improvement of the physical, metabolic and dialytic parameters.
There are only few studies that have measured the impact of a long term intradialytic exercise intervention on a supervised manner. This is a multi-center controlled study examining the effects of intradialytic cycling on parameters of physical functioning, body composition, cardiovascular and nutritional status, immunological status and quality of life in a group of clinically stable hemodialysis patients
Read the detailed description
General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.
These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.
The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.
Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.
The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.
Principal objective :
The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).
Secondary objectives :
The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.
This is a multicenter, controlled randomized trial
Study description:
Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.
The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program
Primary judgment criteria :
The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.
The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)
Secondary criteria:
- Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.
- Physical activity levels: IPAQ (international physical activity questionary).
- Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).
- Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration
- Immune parameters: leucocyte subpopulation functioning
- Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).
- Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)
- Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).
- Number, etiology and duration of hospitalisations
- Survival in 1 year
Number of participants : 100, ie 50 per group
Layout of the study :
Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).
Benefits and risks of this study :
Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.
The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.
Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study
- Conditions
- End Stage Renal Disease on Hemodialysis
- Being tested
- Intradialytic exercise on stationary bicycles, Non-exercising group
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intradialytic exercise on stationary bicyclesBehavioural
Patients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14
Non-exercising groupBehavioural
Patients are having their usual physical activity
| Study group | Role | What they receive |
|---|---|---|
| Exercisers | Active comparator | Intradialytic exercise on stationary bicycles Receives: Behavioral: Intradialytic exercise on stationary bicycles |
| Non Exercisers | Placebo comparator | No intradialytic exercise Receives: Behavioral: Non-exercising group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Improvement of the distance covered after walking for 6 minutes (6 minutes walk test)
The principal aim of the present study is to show the efficacy of intradialytic physical activity on the improvement of the physical capacity of the patients assessed with the 6 minutes walk test ((6MWT)
Measured: 12 months
Secondary outcomes (29)
Quality of life parameters 1
Quality of life parameters evaluated from the questionnaire SF36 QD
Measured: 12 months
Quality of life parameters 2
Quality of life parameters evaluated from the questionnaire Borg scale
Measured: 12 months
Quality of life parameters 3
Quality of life parameters evaluated from the EVA scale
Measured: 12 months
Physical activity levels
Physical activity levels from the questionnary IPAQ (international physical activity questionnairy)
Measured: 12 months
Body composition
Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA ccanning and bioimpendance
Measured: 12 months
Cardiovascular parameters
Cardiovascular parameters : Cardiac echography, echodoppler of the carotid arteries and the lower extremity arteries, 24h cardiac rythm exploration
Measured: 12 months
Immune parametres
Immune parametres: leucocyte subpopulation fonctioning
Measured: 12 months
Nutritional and metabolic parameters 1
BMI
Measured: 12 months
Nutritional and metabolic parameters 2
serum albumin levels
Measured: 12 months
Nutritional and metabolic parameters 3
serum prealbumin levels
Measured: 12 months
Nutritional and metabolic parameters 4
pre and post dialytic serum urea levels
Measured: 12 months
Nutritional and metabolic parameters 5
pre and post dialytic serum creatinine levels
Measured: 12 months
Nutritional and metabolic parameters 6
nPCR (normalised Protein Catabolic Rate)
Measured: 12 months
inflammatory parameters 1
IL1 bêta
Measured: 12 months
inflammatory parameters 2
IL6
Measured: 12 months
inflammatory parameters 3
IL8
Measured: 12 months
inflammatory parameters 4
IL-10
Measured: 12 months
inflammatory parameters 5
TNF alpha
Measured: 12 months
inflammatory parameters 6
CRP
Measured: 12 months
Dialysis parameters
Kt/V
Measured: 12 months
Anemia control 1
Hemoglobin (Hb)
Measured: 12 months
Anemia control 2
MCV (mean corpuscular volume)
Measured: 12 months
Anemia control 3
Ferritine
Measured: 12 months
Anemia control 4
Erythropoetine dosage (EPO).
Measured: 12 months
Number of hospitalisations
Number of hospitalisations
Measured: 12 months
Duration of hospitalisations
Duration of hospitalisations
Measured: 12 months
Survival
Survival in one year
Measured: 12 months
Improvement of Sit to Stand test in 60 seconds (STS60)
The physical capacity of the patients assessed with the number of cycles performed during a sit-to-stand test in 60 seconds (STS60).
Measured: 12 months
Improvement of the time needed to perform 5 Sit to Stand cycles (STS5)
Time needed to perform 5 Sit to Stand cycles (STS5)
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Aug 2016 (estimated)
- Study startSep 2016
- Primary completionSep 2018 (estimated)
- Study completionMay 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End Stage Renal Disease on HemodialysisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- AURA Sante
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02860312
- Sponsor's protocol ID
- AURAS
- Other IDs
- ID-RCB 2015-A0031-48
- Status last verified
- Aug 2016
- First submitted
- 14 Jul 2016
- Last updated
- 9 Aug 2016
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Aug 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of One Year Perdialytic Physical Activity on Aerobic Capacities and Quality of Life in Hemodialysis Patients
- ClinicalTrials.gov ID
- NCT02860312
- Acronym / sponsor ID
- AURAS
- Conditions
- End Stage Renal Disease on Hemodialysis
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- AURA SanteUniversity, hospital or other
- Study start
- Sep 2016
- Primary completion
- Sep 2018 (estimated)
- Study completion
- May 2019 (estimated)
- First posted
- 9 Aug 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. There are several studies- usually short term, single center uncontrolled and underpowered- that have shown a significant improvement of the physical, metabolic and dialytic parameters.
There are only few studies that have measured the impact of a long term intradialytic exercise intervention on a supervised manner. This is a multi-center controlled study examining the effects of intradialytic cycling on parameters of physical functioning, body composition, cardiovascular and nutritional status, immunological status and quality of life in a group of clinically stable hemodialysis patients
Detailed description
General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.
These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.
The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.
Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.
The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.
Principal objective :
The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).
Secondary objectives :
The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.
This is a multicenter, controlled randomized trial
Study description:
Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.
The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program
Primary judgment criteria :
The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.
The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)
Secondary criteria:
- Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.
- Physical activity levels: IPAQ (international physical activity questionary).
- Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).
- Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration
- Immune parameters: leucocyte subpopulation functioning
- Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).
- Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)
- Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).
- Number, etiology and duration of hospitalisations
- Survival in 1 year
Number of participants : 100, ie 50 per group
Layout of the study :
Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).
Benefits and risks of this study :
Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.
The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.
Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Exercisers | Active comparator | Behavioral: Intradialytic exercise on stationary bicyclesIntradialytic exercise on stationary bicycles |
| Non Exercisers | Placebo comparator | Behavioral: Non-exercising groupNo intradialytic exercise |
Who may qualify
- Ages
- 20 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o.
Key exclusion criteria (7 listed)
- Unstable angina,
- severe left ventricular dysfunction,
- Ejection fraction < 30%,
- severe peripheral arterial disease,
- lower extremity amputation,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intradialytic exercise on stationary bicyclesPatients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14 | Behavioural | Exercisers |
| Non-exercising groupPatients are having their usual physical activity | Behavioural | Non Exercisers |
Primary outcome
Improvement of the distance covered after walking for 6 minutes (6 minutes walk test)
Time frame: 12 months
The principal aim of the present study is to show the efficacy of intradialytic physical activity on the improvement of the physical capacity of the patients assessed with the 6 minutes walk test ((6MWT)
29 secondary outcomes
Quality of life parameters 1
Time frame: 12 months
Quality of life parameters 2
Time frame: 12 months
Quality of life parameters 3
Time frame: 12 months
Physical activity levels
Time frame: 12 months
Body composition
Time frame: 12 months
Cardiovascular parameters
Time frame: 12 months
Immune parametres
Time frame: 12 months
Nutritional and metabolic parameters 1
Time frame: 12 months
Nutritional and metabolic parameters 2
Time frame: 12 months
Nutritional and metabolic parameters 3
Time frame: 12 months
Nutritional and metabolic parameters 4
Time frame: 12 months
Nutritional and metabolic parameters 5
Time frame: 12 months
Nutritional and metabolic parameters 6
Time frame: 12 months
inflammatory parameters 1
Time frame: 12 months
inflammatory parameters 2
Time frame: 12 months
inflammatory parameters 3
Time frame: 12 months
inflammatory parameters 4
Time frame: 12 months
inflammatory parameters 5
Time frame: 12 months
inflammatory parameters 6
Time frame: 12 months
Dialysis parameters
Time frame: 12 months
Anemia control 1
Time frame: 12 months
Anemia control 2
Time frame: 12 months
Anemia control 3
Time frame: 12 months
Anemia control 4
Time frame: 12 months
Number of hospitalisations
Time frame: 12 months
Duration of hospitalisations
Time frame: 12 months
Survival
Time frame: 12 months
Improvement of Sit to Stand test in 60 seconds (STS60)
Time frame: 12 months
Improvement of the time needed to perform 5 Sit to Stand cycles (STS5)
Time frame: 12 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Aug 2016.
- Individual participant dataSharing planned: No
Related trials for End Stage Renal Disease on Hemodialysis
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Not yet recruitingPhase 1/2
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
End Stage Renal Disease, Fatigue
Active, not recruitingPhase 2
Management of Iron Deficiency Anemia in Hemodialysis Patients
Iron Deficiency Anemia (IDA), ESRD (End Stage Renal Disease)
Not yet recruiting
Effects of Horticultural Therapy on Acute Stress and Salivary Cortisol Levels in Hemodialysis Patients
End-Stage Renal Disease, Renal Dialysis
Active, not recruitingPhase 1/2
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Intradialytic exercise on stationary bicycles and Non-exercising group in people with End Stage Renal Disease on Hemodialysis, run by AURA Sante.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Improvement of the distance covered after walking for 6 minutes (6 minutes walk test) (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2016.